Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results.


Journal

Clinical & experimental metastasis
ISSN: 1573-7276
Titre abrégé: Clin Exp Metastasis
Pays: Netherlands
ID NLM: 8409970

Informations de publication

Date de publication:
04 2023
Historique:
received: 11 01 2023
accepted: 10 03 2023
medline: 20 4 2023
pubmed: 4 4 2023
entrez: 3 4 2023
Statut: ppublish

Résumé

PSICHE (NCT05022914) is a prospective trial to test a [

Identifiants

pubmed: 37012498
doi: 10.1007/s10585-023-10204-y
pii: 10.1007/s10585-023-10204-y
pmc: PMC10113311
doi:

Substances chimiques

Gallium Radioisotopes 0
Gallium Isotopes 0
Prostate-Specific Antigen EC 3.4.21.77

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

197-201

Subventions

Organisme : NCI NIH HHS
ID : UG1 CA233340
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

Lancet. 2020 Apr 11;395(10231):1208-1216
pubmed: 32209449
J Urol. 2013 Aug;190(2):441-9
pubmed: 23707439
Eur Urol. 2021 Feb;79(2):263-282
pubmed: 33039206
Lancet. 2021 May 22;397(10288):1895-1904
pubmed: 33971152
J Clin Oncol. 2022 Oct 10;40(29):3377-3382
pubmed: 36001857
Eur Urol. 2018 Apr;73(4):485-487
pubmed: 29132714
Crit Rev Oncol Hematol. 2019 Jun;138:24-28
pubmed: 31092381
Radiother Oncol. 2007 Aug;84(2):121-7
pubmed: 17706307
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S10-9
pubmed: 20171502
Eur Urol Oncol. 2022 Feb;5(1):44-51
pubmed: 34785189

Auteurs

Giulio Francolini (G)

Radiation Oncology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Michele Ganovelli (M)

Department of Biomedical, Experimental and Clinical Sciences, Serio" University of Florence, Florence, Italy.

Vanessa Di Cataldo (V)

Radiation Oncology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Beatrice Detti (B)

Radiation Oncology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy. beatrice.detti@aouc.unifi.it.
Radiation Oncology Department, AOU Careggi, Viale Morgagni 85, Florence, 50134, Italy. beatrice.detti@aouc.unifi.it.

Saverio Caini (S)

Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.

Mauro Loi (M)

Radiation Oncology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Gabriele Simontacchi (G)

Radiation Oncology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Isacco Desideri (I)

Department of Biomedical, Experimental and Clinical Sciences, Serio" University of Florence, Florence, Italy.

Daniela Greto (D)

Radiation Oncology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Marianna Valzano (M)

Department of Biomedical, Experimental and Clinical Sciences, Serio" University of Florence, Florence, Italy.

Sergio Serni (S)

Unit of Urological Robotic Surgery and Renal Transplantation, University of Florence, Careggi Hospital, Florence, Italy.
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Luca Vaggelli (L)

Nuclear Medicine Division, Careggi University Hospital, Florence, Italy.

Viola Salvestrini (V)

CyberKnife Center, Istituto Fiorentino di Cura e Assistenza (IFCA), Florence, Italy.

Luca Visani (L)

CyberKnife Center, Istituto Fiorentino di Cura e Assistenza (IFCA), Florence, Italy.

Carlotta Becherini (C)

Radiation Oncology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Emanuela Olmetto (E)

Radiation Oncology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Ciro Franzese (C)

Radiation Oncology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Davide Baldaccini (D)

Radiation Oncology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Marta Scorsetti (M)

Radiation Oncology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Martina Sollini (M)

Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090 Pieve Emanuele, Milan, Italy.

Arturo Chiti (A)

Nuclear Medicine Department, IRCCS San Raffaele, Milan, Italy.

Icro Meattini (I)

Department of Biomedical, Experimental and Clinical Sciences, Serio" University of Florence, Florence, Italy.

Richard K Valicenti (RK)

Department of Radiation Oncology, UC Davis, Davis, CA, USA.

Lorenzo Livi (L)

Department of Biomedical, Experimental and Clinical Sciences, Serio" University of Florence, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH